News & Perspective

Aug 15, 2008

Aug 15, 2008

FBI conclusions in anthrax probe meet skepticism

(CIDRAP News) – The Federal Bureau of Investigation's (FBI's) recently revealed conclusion that the late anthrax researcher Dr. Bruce Ivins committed the anthrax letter attacks of 2001 has been greeted with skepticism by many in the scientific community.

Aug 12, 2008

Aug 12, 2008

HHS evaluates proposals for new anthrax vaccine

(CIDRAP News) – Two Maryland pharmaceutical companies recently announced that they have submitted proposals to produce and deliver at least 25 million doses of a next-generation anthrax vaccine to the nation's Strategic National Stockpile.

Jun 27, 2006

Jun 27, 2006

DHS starts work on $128 million biodefense center

(CIDRAP News) – Department of Homeland Security (DHS) officials broke ground yesterday for the National Biodefense Analysis and Countermeasures Center (NBACC) at Fort Detrick in Frederick, Md.

Construction of the NBACC is slated for completion in 2008, DHS officials said in a news release. The facility's estimated cost is $128 million, according to an April 2005 Congressional Research Service (CRS) report.

May 09, 2006

May 09, 2006

Vaccine may permit shorter antibiotic course for anthrax

(CIDRAP News) – Combining vaccination with 14 days of antibiotic therapy after exposure to airborne anthrax may be an alternative to the current recommendation of 60 days of antibiotics alone, according to an animal study reported in the Proceedings of the National Academy of Sciences.

May 02, 2006

May 02, 2006

Postexposure Marburg vaccination protects monkeys

(CIDRAP News) – An experimental vaccine protected monkeys from the deadly Marburg hemorrhagic fever virus even though they weren't vaccinated until after exposure, according to a report published in the April 29 issue of The Lancet.

Jun 07, 2005

Jun 07, 2005

Ebola, Marburg vaccines work in monkeys

(CIDRAP News) – A pair of vaccines created by a Canadian-based international team of researchers protected monkeys against the lethal Ebola and Marburg viruses, according to a new report in Nature Medicine.

Nov 04, 2004

Nov 04, 2004

HHS to spend $877 million on new anthrax vaccine

Editor's note: A correction was made in this story Nov 9 to note that the existing licensed anthrax vaccine contains the natural rather than recombinant form of anthrax protective antigen.

(CIDRAP News) – Federal health officials today announced the award of an $877 million contract for 75 million doses of a new anthrax vaccine to protect the public and improve on the existing vaccine used by the military.

Oct 14, 2004

Oct 14, 2004

Monkeys serve as first animal model of smallpox

(CIDRAP News) – Federal researchers report they have succeeded in infecting monkeys with fatal smallpox, creating the first animal model of the disease for use in testing vaccines and treatments for humans.

Sep 01, 2004

Sep 01, 2004

Inhaled anthrax vaccine tested in animals

(CIDRAP News) – US Army and private researchers have developed a powdered anthrax vaccine that looks promising in initial animal studies and could eliminate the need for needle injections, according to the American Chemical Society (ACS).

Mar 25, 2004

Mar 25, 2004

Vaccine prevents flea-borne plague in mice

(CIDRAP News) – An experimental plague vaccine completely protected mice that were bitten by fleas carrying the plague pathogen, in a study that reproduced the natural transmission pathway for bubonic plague, according to the National Institute of Allergy and Infectious Disease (NIAID).

Pages

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»